Influence of estradiol supplementation on neuropeptide Y neurotransmission in skeletal muscle arterioles of F344 rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 303, Issue 6, 2012, Pages

  Evanson, Kirk W ^a   Stone, Audrey J ^a   Samraj, Enoch ^b   Benson, Tyler ^b   Prisby, Rhonda ^c   Kluess, Heidi A ^d  

^a UNIVERSITY OF ARKANSAS   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

^d AUBURN UNIVERSITY   (United States)

Author keywords

Arteriole; Dipeptidyl peptidase IV; Estradiol; Estrogen; Neuropeptide Y; Sex; Steroid; Supplementation; Sympathetic

Indexed keywords

DIPROTIN A; ESTRADIOL; NEUROPEPTIDE Y; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; SODIUM CHLORIDE; ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY CATHETERIZATION; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; FISCHER 344 RAT; GASTROCNEMIUS MUSCLE; MICROPIPETTE; NEUROTRANSMISSION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SKELETAL MUSCLE; SUPPLEMENTATION; VASOCONSTRICTION; CANNULATION; ANIMAL; DRUG EFFECT; DRUG IMPLANT; GENE EXPRESSION REGULATION; GENETICS; INNERVATION; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION; VASCULARIZATION;

ANIMALS; ARTERIOLES; DRUG IMPLANTS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; MUSCLE, SKELETAL; NEUROPEPTIDE Y; OVARIECTOMY; RATS; SYNAPTIC TRANSMISSION;

EID: 84866397952     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00072.2012     Document Type: Article

References (50)

1. Abel PW, Han C. Effects of neuropeptide Y on contraction, relaxation, and membrane potential of rabbit cerebral arteries. J Cardiovasc Pharmacol 13: 52-63, 1989.
2. Andriantsitohaina R, Stoclet JC. Enhancement by neuropeptide Y (NPY) of the dihydropyridine-sensitive component of the response to alpha 1-adrenoceptor stimulation in rat isolated mesenteric arterioles. Br J Pharmacol 99: 389-395, 1990.
3. Brandin L, Bergstrom G, Manhem K, Gustafsson H. Oestrogen modulates vascular adrenergic reactivity of the spontaneously hypertensive rat. J Hypertens 21: 1695-1702, 2003.
4. Cai DJ, Zhao Y, Glasier J, Cullen D, Barnes S, Turner CH, Wastney M, Weaver CM. Comparative effect of soy protein, soy isoflavones, and 17beta-estradiol on bone metabolism in adult ovariectomized rats. J Bone Miner Res 20: 828-839, 2005.
5. Clarke J, Benjamin N, Larkin S, Webb D, Maseri A, Davies G. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man. Circulation 83: 774-777, 1991.
6. Delp MD, Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J Appl Physiol 80: 261-270, 1996.
7. Donoso MV, Brown N, Carrasco C, Cortes V, Fournier A, Huidobro-Toro JP. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors. J Neurochem 69: 1048-1059, 1997.
8. Evanson KW, Stone AJ, Hammond AL, Kluess HA. Neuropeptide Y overflow and metabolism in skeletal muscle arterioles. J Physiol 589: 3309-3318, 2011.
9. Garcia-Villalon AL, Buchholz JN, Duckles SP, Krause DN. Noradrenaline content and release in male and female rat tail arteries. J Cardiovasc Pharmacol 29: 93-96, 1997.
10. Glenn TC, Krause DN, Duckles SP. Vascular responses to neuropeptide Y are greater in female than male rats. Naunyn Schmiedebergs Arch Pharmacol 355: 111-118, 1997.
11. Gustafsson H, Nilsson H. Endothelium-independent potentiation by neuropeptide Y of vasoconstrictor responses in isolated arteries from rat and rabbit. Acta Physiol Scand 138: 503-507, 1990.
12. Haim S, Shakhar G, Rossene E, Taylor AN, Ben-Eliyahu S. Serum levels of sex hormones and corticosterone throughout 4-and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females. J Endocrinol Invest 26: 1013-1022, 2003.
13. Han S, Yang CL, Chen X, Naes L, Cox BF, Westfall T. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction. Am J Physiol Heart Circ Physiol 274: H290-H294, 1998.
14. Hanko JH, Tornebrandt K, Hardebo JE, Kahrstrom J, Nobin A, Owman C. Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man. J Auton Pharmacol 6: 117-124, 1986.
15. Jackson DN, Ellis CG, Shoemaker JK. Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 298: R1351-R1357, 2010.
16. Jackson DN, Milne KJ, Noble EG, Shoemaker JK. Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats. J Physiol 562: 285-294, 2005.
17. Jackson DN, Milne KJ, Noble EG, Shoemaker JK. Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats. J Physiol 568: 573-581, 2005.
18. Joshua IG. Neuropeptide Y-induced constriction in small resistance vessels of skeletal muscle. Peptides 12: 37-41, 1991.
19. Kim D, Duran WR, Kobayashi I, Daniels AJ, Duran WN. Microcirculatory dynamics of neuropeptide Y. Microvasc Res 48: 124-134, 1994.
20. Lacroix JS. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand Suppl 581: 1-63, 1989.
21. LeBlanc AJ, Reyes R, Kang LS, Dailey RA, Stallone JN, Moningka NC, Muller-Delp JM. Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 297: R1713-R1723, 2009.
22. Luksha L, Poston L, Gustafsson JA, Aghajanova L, Kublickiene K. Gender-specific alteration of adrenergic responses in small femoral arteries from estrogen receptor-beta knockout mice. Hypertension 46: 1163-1168, 2005.
23. Lundberg JM, Franco-Cereceda A, Lacroix JS, Pernow J. Neuropeptide Y and sympathetic neurotransmission. Ann NY Acad Sci 611: 166-174, 1990.
24. Lundberg JM, Pernow J, Franco-Cereceda A, Rudehill A. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y. J Cardiovasc Pharmacol 10, Suppl 12: S51-S68, 1987.
25. Lundberg JM, Rudehill A, Sollevi A, Theodorsson-Norheim E, Hamberger B. Frequency-and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett 63: 96-100, 1986.
26. Lundberg JM, Terenius L, Hokfelt T, Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42: 167-172, 1983.
27. Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom S, Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116: 477-480, 1982.
28. McAuley MA, Westfall TC. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. J Pharmacol Exp Ther 261: 863-868, 1992.
29. Mehrotra S, Gupta S, Villalon CM, Boomsma F, Saxena PR, MaassenVanDenbrink A. Rat carotid artery responses to alpha-adrenergic receptor agonists and 5-HT after ovariectomy and hormone replacement. Headache 47: 236-246, 2007.
30. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 60: 210-241, 2008.
31. Moriarty K, Kim KH, Bender JR. Minireview: estrogen receptormediated rapid signaling. Endocrinology 147: 5557-5563, 2006.
32. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 45: 522-525, 2005.
33. Pernow J, Ohlen A, Hokfelt T, Nilsson O, Lundberg JM. Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man. Regul Pept 19: 313-324, 1987.
34. Pourageaud F, De Mey JG. Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries. Am J Physiol Heart Circ Physiol 274: H1301-H1307, 1998.
35. Rachon D, Seidlova-Wuttke D, Vortherms T, Wuttke W. Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats. Maturitas 58: 308-315, 2007.
36. Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23: 279-302, 2002.
37. Roepke TA. Oestrogen modulates hypothalamic control of energy homeostasis through multiple mechanisms. J Neuroendocrinol 21: 141-150, 2009.
38. Scharpe S, De Meester I, Vanhoof G, Hendriks D, van Sande M, Van Camp K, Yaron A. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. Clin Chem 34: 2299-2301, 1988.
39. Schneider F, Bucher B, Schott C, Andre A, Julou-Schaeffer G, Stoclet JC. Effect of bacterial lipopolysaccharide on function of rat small femoral arteries. Am J Physiol Heart Circ Physiol 266: H191-H198, 1994.
40. Segal SS. Regulation of blood flow in the microcirculation. Microcirculation 12: 33-45, 2005.
41. Small DL, Bolzon BJ, Cheung DW. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery. Eur J Pharmacol 210: 131-136, 1992.
42. Stice JP, Eiserich JP, Knowlton AA. Role of aging versus the loss of estrogens in the reduction in vascular function in female rats. Endocrinology 150: 212-219, 2009.
43. Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328: 688-696, 2005.
44. Tarnopolsky MA. Sex differences in exercise metabolism and the role of 17-beta estradiol. Med Sci Sports Exerc 40: 648-654, 2008.
45. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659-660, 1982.
46. Tivesten A, Moverare-Skrtic S, Chagin A, Venken K, Salmon P, Vanderschueren D, Savendahl L, Holmang A, Ohlsson C. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats. J Bone Miner Res 19: 1833-1839, 2004.
47. Vu HQ, Budai D, Duckles SP. Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction. J Pharmacol Exp Ther 251: 852-857, 1989.
48. Wahlestedt C, Grundemar L, Hakanson R, Heilig M, Shen GH, Zukowska-Grojec Z, Reis DJ. Neuropeptide Y receptor subtypes, Y1 and Y2. Ann NY Acad Sci 611: 7-26, 1990.
49. Williams DA, Segal SS. Feed artery role in blood flow control to rat hindlimb skeletal muscles. J Physiol 463: 631-646, 1993.
50. Xia J, Neild TO, Kotecha N. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain. Br J Pharmacol 107: 771-776, 1992.